GlassScriptPhysician profile
Mark H Bronner
NPI 1841274388
$2,868.90
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $479 · 2021: $95.90 · 2022: $291 · 2023: $162 · 2024: $20.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $555.65 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $506.39 | 2019-2023 | Entyvio |
| Janssen Biotech, INC. | $391.07 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $337.78 | 2019-2022 | |
| Pfizer INC. | $258.83 | 2019-2023 | |
| Ucb, INC. | $183.55 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $129.62 | 2019-2023 | Rebyota |
| Evoke Pharma, INC. | $108.97 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $71.64 | 2022-2023 | Dupixent |
| Ironwood Pharmaceuticals, INC | $51.99 | 2020-2022 | |
| Gilead Sciences, INC. | $45.56 | 2019-2020 | |
| Braintree Laboratories, INC. | $35.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $29.70 | 2019 | |
| Csl Behring | $27.30 | 2019-2020 | |
| Boston Scientific Corporation | $20.37 | 2024 | Watchman Access System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $17.42 | 2023 | Ibsrela |
| Shire North American Group INC | $16.16 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.16 | 2020 | |
| Intercept Pharmaceuticals, INC. | $13.01 | 2020 | |
| Medtronic, INC. | $12.87 | 2023 | Gi Genius |
| Shionogi INC | $12.68 | 2019 | |
| Dova Pharmaceuticals | $11.59 | 2019 | |
| Allergan, INC. | $10.88 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $6.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bronner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.